Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Merck
Healthtrust
Baxter
Deloitte
Harvard Business School

Generated: May 26, 2019

DrugPatentWatch Database Preview

DEXAMETHASONE SODIUM PHOSPHATE Drug Profile

« Back to Dashboard

Which patents cover Dexamethasone Sodium Phosphate, and what generic alternatives are available?

Dexamethasone Sodium Phosphate is a drug marketed by Akorn, Amneal Pharms Co, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Fresenius Kabi Usa, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz Inc. and is included in thirty-three NDAs.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.

Drug patent expirations by year for DEXAMETHASONE SODIUM PHOSPHATE
Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE
Synonyms for DEXAMETHASONE SODIUM PHOSPHATE
(11beta,16alpha)-9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
1869-92-7
21-Disodium phosphate dexamethasone
2392-39-4
392D394
3tc5
54302-EP2305219A1
54302-EP2308562A2
54302-EP2371811A2
55203-24-2
65184-38-5
9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) disodium salt
A816989
A830522
AB1009274
AC-17992
AC1L291E
AC1NTURW
AC1Q1UXS
AI9376Y64P
Ak-Dex
AKOS015896357
AKOS015951212
AM84812
AN-14018
AN-40448
AN-50017
B1588
Baldex
BC213122
BCP16805
BDBM235670
C08175
C22H28FNa2O8P
C22H28FO8P.2Na
CAS-2392-39-4
CHEBI:4462
CHEBI:68638
CHEMBL1200637
CHEMBL2021430
Colvasone
CS-0013899
D00975
Dalalone
Dalalone (TN)
Decadron Inhalation, Injection, Ophthalmic Solution and Ointment, and Topical Cream
Decadron phosphate
Decdan
Dexabene
Dexadreson
Dexagel
Dexagro
Dexaject SP
Dexamethason sodium phosphate
Dexamethasone 21-(disodium phosphate)
Dexamethasone 21-(sodium hydrogen phosphate)
Dexamethasone 21-phosphate disodium salt
Dexamethasone 21-phosphate disodium salt, >=98%
Dexamethasone disodium phosphate
Dexamethasone phosphate disodium
dexamethasone phosphate(2-)
Dexamethasone sodium phosphate (JAN/USP)
Dexamethasone Sodium Phosphate [USAN:BAN:JAN]
Dexamethasone sodium phosphate [USP:BAN:JAN]
Dexamethasone sodium phosphate for peak identification, European Pharmacopoeia (EP) Reference Standard
Dexamethasone sodium phosphate, British Pharmacopoeia (BP) Reference Standard
Dexamethasone sodium phosphate, European Pharmacopoeia (EP) Reference Standard
Dexamethasone Sodium Phosphate, Pharmaceutical Secondary Standard; Certified Reference Material
Dexamethasone sodium phosphate, United States Pharmacopeia (USP) Reference Standard
Dexamethasone-21-phosphate disodium salt
Dexamethazone sodium phosphate
disodium (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-14-[2-(phosphonatooxy)acetyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one
disodium (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-14-[2-(phosphonatooxy)acetyl]tetracyclo[8.7.0.0?,?.0??,??]heptadeca-3,6-dien-5-one
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoranyl-10,13,16-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxidanylidene-ethyl] phosphate
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] phosphate
disodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
disodium 9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl phosphate
Disodium dexamethasone phosphate
disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
DSSTox_CID_27429
DSSTox_GSID_47429
DSSTox_RID_82342
DTXSID3047429
EINECS 217-487-2
EINECS 219-243-0
EN300-52795
FT-0603099
FT-0659571
Hexadrol Injectable
HMS2231O20
HY-B1829A
I06-1906
J10230
KB-296233
KS-1150
LS-118471
Maxidex Ointment
Megacort
MFCD00079105
MLS000069568
MLS000863280
MLS001076081
MolPort-002-529-303
MolPort-005-937-094
MQRFYYBWKRACSJ-WKSAPEMMSA-M
NCGC00021226-03
NCGC00021226-04
NCGC00021226-05
NCGC00094644-01
NCGC00256783-01
Onadron
Opera_ID_74
Orgadrone
Phosphoric acid hydrogen (9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl)=sodium ester salt
PLCQGRYPOISRTQ-FCJDYXGNSA-L
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 21-(dihydrogen phosphate) disodium salt
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, disodium salt, (11beta,16alpha)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, sodium salt (1:2), (11beta,16alpha)-
Q-200940
s4028
SC-18764
SCHEMBL3694078
SCHEMBL7778
SMR000058813
sodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] hydrogen phosphate
sodium [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
Sodium dexamethasone phosphate
Soldesam
Solu-Decadron
Spersadox
TL8001979
Tox21_113181
Tox21_302586
UNII-AI9376Y64P

US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 040491-001 Apr 11, 2003 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bausch And Lomb DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC, OTIC 040069-001 Jul 26, 1996 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Somerset Theraps Llc DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 207442-001 Apr 19, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate SOLUTION/DROPS;OPHTHALMIC, OTIC 088771-001 Jan 16, 1985 AT RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Fish and Richardson
Healthtrust
QuintilesIMS
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.